Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation

Mise à jour : Il y a 5 ans
Référence : NCT00383864

Femme et Homme

  • | Pays :
  • Spain
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study was to evaluate the efficacy (and safety) of antiviral therapy in patients with chronic hepatitis C after liver transplantation. The only approved drugs for treatment of hepatitis C are pegylated interferon and ribavirin.


Critère d'inclusion

  • Hepatitis C

Liens